Biotech Series B Investors & VC Firms
947 firms in this list, with a median first check of $540K. 211 of them lead rounds. Generated from verified public data and updated continuously.
Andreessen Horowitz
Menlo ParkSeed–Late Stage$500K – $50M
134 people
New Enterprise Associates (NEA)
Menlo ParkSeed–Late Stage$200K – $40M
72 people
Bessemer Venture Partners
Redwood CitySeed–Late Stage$5M – $100M
61 people
Khosla Ventures
Menlo ParkPre-Seed–Late Stage$5K – $50M
51 people
Sequoia Capital
Menlo ParkPre-Seed–Late Stage$4.4M – $214M
47 people
F-Prime Capital
CambridgePre-Seed–Late Stage$3M – $10M
110 people
General Catalyst
San FranciscoPre-Seed–Late Stage$30M
33 people
OrbiMed
New YorkPre-Seed–Late Stage$1M – $75M
131 people
Kleiner Perkins
Menlo ParkPre-Seed–Late Stage$500K – $15M
50 people
GV (Google Ventures)
Mountain ViewSeed–Late Stage$250K – $50M
54 people
Norwest Venture Partners
Menlo ParkSeed–Late Stage$10M – $30M
35 people
Felicis Ventures
San FranciscoPre-Seed–Series C$500K – $15M
53 people
RA Capital
BostonSeed–Late Stage
86 people
Menlo Ventures
San FranciscoPre-Seed–Growth$1M – $20M
57 people
8VC
AustinPre-Seed–Late Stage$100K – $50M
58 people
DCVC (Data Collective)
Palo AltoPre-Seed–Late Stage$5M – $25M
44 people
Elevate Ventures
IndianapolisPre-Seed–Growth$20K – $2M
29 people
Bain Capital Venture
BostonPre-Seed–Late Stage
162 people
Madrona Venture Group
SeattlePre-Seed–Growth$2M – $10M
67 people
Founders Fund
San FranciscoSeed–Late Stage$500K – $5M
38 people
Qiming Venture Partners
BeijingSeed–Growth$5M – $134M
17 people
Venrock
Palo AltoSeed–Late Stage$500K – $10M
57 people
Lux Capital
New YorkPre-Seed–Growth$100K – $100M
51 people
Sofinnova Partners
ParisPre-Seed–Late Stage$540K – $27M
89 people
Frequently asked questions
- Who are the top biotech series b investors & vc firms?
- Top biotech series b investors & vc firms include Andreessen Horowitz, New Enterprise Associates (NEA), Bessemer Venture Partners, Khosla Ventures, Sequoia Capital, F-Prime Capital, General Catalyst, OrbiMed — 947 firms in total meet the criteria.
- What is the typical first check among biotech series b investors & vc firms?
- The median first check among the 947 biotech series b investors & vc firms tracked here is $540K.
- How many biotech series b investors & vc firms lead rounds?
- 211 of the 947 biotech series b investors & vc firms tracked here lead investment rounds.
Related lists
Series B Investors & VC Firms (4259)Series B Investors & VC Firms in North America (2319)Biotech Investors & VC Firms (2185)Series B Investors & VC Firms in United States (2067)Biotech Seed Investors & VC Firms (1824)Biotech Series A Investors & VC Firms (1668)SaaS Series B Investors & VC Firms (1448)Series B Investors & VC Firms in Europe (1431)Biotech Investors & VC Firms in North America (1391)Series B Investors & VC Firms in Asia-Pacific (1381)
Data sourced from public filings and firms' own websites — see our methodology.























.png)













































































